Accella Performance Materials, a portfolio company of Arsenal Capital Partners, has acquired IPS Polymer Systems, a manufacturer of polyurethane and polyurea products.
IPS Polymer Systems serves a wide variety of industries and has more than 5,000 proprietary polyurethane formulations. The company can also custom formulate products to meet the specific product needs of customers. IPS was founded in 1984 by its CEO Ezzat Seif and is based east of Los Angeles in Rancho Cucamonga, CA (www.ipspolymer.com).
Accella is a manufacturer of custom formulated polyurethane systems, specialty vinyl plastisols and recycled rubber products. The polyurethane business is focused on tire-fill, foams, adhesives, sealants and elastomers. Primary end-use products for plastisols include caps and closures, adhesives and carpet/rug backings. The recycled rubber products business manufactures recycled tire crumb, equine matting, athletic flooring, playground surfacing and custom molded products. The company has ten production facilities across the United States, one in the UK, one in Germany, and one in China. Accella is headquartered in the St. Louis suburb of Maryland Heights (www.accellacorp.com).
The acquisition of IPS furthers Accella’s strategy to build the leading polyurethane systems company in North America. “IPS and Accella have over 40 years of experience with polyurethane technology and proprietary formulations,” said Accella’s CEO, Andy Harris. “IPS is an excellent fit with Accella’s current polyurethanes business and will bring expanded technology and capabilities to both companies. The acquisition of IPS is strategic in our objective to build the leading independent polyurethane systems house in North America.”
“We are very pleased to bring IPS Polymer Systems into the Accella group, and with the progress of Accella overall. IPS strengthens the Accella polyurethanes platform and will enhance the value Accella brings to market. We are committed to support the ongoing growth of Accella and will continue to invest in strategic opportunities that will further transform the business,” said John Televantos, Partner at Arsenal Capital.
Arsenal Capital Partners invests in middle-market specialty industrial and healthcare companies that have $50 million to $250 million in enterprise value. Industries of specific interest include specialty & fine chemicals; segments of healthcare; transportation and logistics; power generation; aerospace & defense; and process industry components and services. Arsenal has $1.7 billion of committed capital under management. The firm was founded in 2000 and has offices in New York and Shanghai (www.arsenalcapital.com).
© 2015 PEPD • Private Equity’s Leading News Magazine • 3-3-15